Printer Friendly
The Free Library
19,585,952 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Biora AB Announces Year End Report 2000.


Business Editors

MALMO, Sweden--(BUSINESS WIRE)--Feb. 8, 2001

Biora AB (publ)(NASDAQ NASDAQ
 in full National Association of Securities Dealers Automated Quotations

U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on
:BIORY)(SSE (1) An earlier full-screen editor in OS/2.

(2) (Streaming SIMD Extensions) A series of additional instructions built into Pentium CPU chips for improved multimedia performance by performing mathematical operations on multiple sets of data at the
:BIOR)

                                                             Percent
                                  2000            1999        Change

Net sales, SEK millions           89.2            73.6         +21
Operating loss, SEK millions    - 78.7          - 91.8
Net loss, SEK millions          - 76.1          - 86.7
-- Sales during 2000 increased by 21 percent to SEK 89.2 million (compared to
SEK 73.6 million for the same period in 1999). The increase during the year
occurred mainly in the U.S. market (+ 51%).

-- Emdogain Gel, a further development of Emdogain that offers an easy-to-use
treatment, is now approved by the Food and Drug Administration (FDA) in the
U.S.

-- The Board of Directors will recommend that the stockholders at the annual
meeting give the Board authority, if deemed necessary, for a new issue of
shares at an appropriate time.

-- Two projects to investigate new areas of use for enamel matrix proteins
within the dental area have been initiated during 2001

-- The Japanese registration authorities view favorably an expedited process
for registration of Emdogain Gel


Biora develops, manufactures and sells pharmaceutical products to dentists and dental hygienists. Its principal product, Emdogain(R), which is approved for sale in Europe, North America North America, third largest continent (1990 est. pop. 365,000,000), c.9,400,000 sq mi (24,346,000 sq km), the northern of the two continents of the Western Hemisphere.  and Japan, naturally regenerates the tooth supporting structure that the tooth has lost due to periodontitis periodontitis

Inflammation of soft tissues around the teeth (see tooth). Poor dental hygiene leads to deposition of bacterial plaque on the teeth below the gum line, irritating and eroding nearby tissues.
. Biora's American Depository The place where a deposit is placed and kept, e.g., a bank, savings and loan institution, credit union, or trust company. A place where something is deposited or stored as for safekeeping or convenience, e.g., a safety deposit box.  Shares are listed on the Nasdaq National Market in the USA and Biora's ordinary shares are listed on the "O-list" of the Stockholm Stock Exchange The Stockholm Stock Exchange (Swedish: Stockholmsbörsen) is a stock exchange located in Stockholm, Sweden. Founded in 1863 [1] it is the primary securities exchange of the Nordic Countries.  in Sweden.

www.biora.com for full detailed report
COPYRIGHT 2001 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2001, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Feb 8, 2001
Words:252
Previous Article:Connecticut Bancshares, Inc. to Acquire First Federal Savings and Loan Association of East Hartford in a Cash Transaction Valued At Approximately...
Next Article:HomeSeekers.com to Announce Second Quarter Results on February 14, 2001.
Topics:



Related Articles
Biora's New Product Approved for Sale in the United States.
Biora Licenses to Medpharma New Product for Treatment of Dry Mouth.
Information About the Proposals by Biora AB's Board of Directors for Authorization to Issue New Shares and for an Option Program for Employees.
Biora AB -Report For the First Nine Months 2001.
Biora Enters Into a Licensing Agreement for Its Wound Healing Project.
Biora AB Appoints New Chief Executive Officer and New Chief Financial Officer.
Biora convenes Extraordinary Shareholders' meeting.
Biora to Delist From Nasdaq On January 31 and Commence Trading On The OTC Market.
Report from Biora's Extraordinary General Meeting.
Biora AB: Year End Report 2001.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles